BEAT BIOTHERAPEUTICS
BEAT BioTherapeutics Corp. (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bio’s first product is based on a fundamental discovery in cardiac muscle contraction and the development of a novel GeneTherapy to improve cardiac performance in the setting of heart failure.
BEAT BIOTHERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2008-01-01
Address:
Bellevue, Washington, United States
Country:
United States
Website Url:
http://www.beatbiotherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
2065430586
Total Funding:
2.5 M USD
Technology used in webpage:
Domain Not Resolving Google Font API Pound Sterling Japanese Yen
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Aperture Therapeutics
Aperture Therapeutics develops novel therapies for neurodegenerative diseases, leveraging genetic diversity.
C4 Therapeutics
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Tacere Therapeutics
Tacere Therapeutics develops therapies to identify and treat diseases.
Current Advisors List
Board_member
2013-01-01
Current Employees Featured
Michael Laflamme Scientific Co-Founder @ BEAT BioTherapeutics
Scientific Co-Founder
Michael Regnier Founder @ BEAT BioTherapeutics
Founder
Buddy Ratner Scientific Co-Founder @ BEAT BioTherapeutics
Scientific Co-Founder
Charles Murry Scientific Co-Founder and Chairman @ BEAT BioTherapeutics
Scientific Co-Founder and Chairman
Founder
Investors List
W Fund
W Fund investment in Seed Round - BEAT BioTherapeutics
CET Capital Partners
CET Capital Partners investment in Seed Round - BEAT BioTherapeutics
Official Site Inspections
http://www.beatbiotherapeutics.com
Unable to get host informations!!!
Cannot get whois informations of this domain!!!
More informations about "BEAT BioTherapeutics"
BEAT BioTherapeutics - Crunchbase Company Profile
BEAT BioTherapeutics Corp. (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bio’s …See details»
BEAT Biotherapeutics Company Profile 2024: Valuation, Funding ...
BEAT Biotherapeutics General Information Description. Developer of novel therapies designed to treat heart failures. The company's therapies are used to treat heart failures by increasing …See details»
BEAT BioTherapeutics Corp - Company Profile and News
Company profile page for BEAT BioTherapeutics Corp including stock price, company news, executives, board members, and contact informationSee details»
BEAT BioTherapeutics - VentureRadar
BEAT BioTherapeutics is developing BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. BEATBio holds worldwide rights to this technology …See details»
BEAT BioTherapeutics - Overview, News & Similar companies
BEAT BioTherapeutics Corp. (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bios f irst product is based on a …See details»
BEAT BioTherapeutics - Products, Competitors, Financials, …
BEAT BioTherapeutics Announces Scientific Presentation at American Society of Gene and Cell Therapy Annual Meeting. May 3, 2016. BEAT BioTherapeutics Announces Scientific …See details»
BEAT BioTherapeutics Corp.: Drug pipelines, Patents, Clinical trials ...
Explore BEAT BioTherapeutics Corp. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Technology Platform:AAV based gene ...See details»
BEAT BioTherapeutics - Funding, Financials, Valuation & Investors
BEAT BioTherapeutics develops novel therapies for heart diseases.See details»
BEAT BioTherapeutics Company Information - Funding, Investors, …
BEAT BioTherapeutics is a company founded to develop novel therapies for heart disease. Seedtable Score 76 Startups. 1. Funding Rounds. $2.5m. Money raised. About; Insights; …See details»
BEAT BioTherapeutics Corp Company Profile, Financial and
BEAT BioTherapeutics Corp., a biotechnology company, develops therapies for the treatment of heart diseases. The company focuses on developing a gene therapy to improve cardiac …See details»
Beat BioTherapeutics - Company Profile - Tracxn
Feb 26, 2025 Beat BioTherapeutics develops therapies for the treatment of heart diseases. The company focuses on developing a gene therapy to improve cardiac performance in the setting …See details»
BEAT BioTherapeutics - Ownership and Business Overview - Mergr
BEAT BioTherapeutics was founded in 2008. Life Science M&A Summary in . Join Mergr to view all 0 acquisitions of life science companies in , including . BEAT BioTherapeutics Corp. 1380 …See details»
BEAT BioTherapeutics - W Fund
BEAT BioTherapeutics Corp. (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bio’s first product is based on a …See details»
BEAT BioTherapeutics Venture Capital and Private Equity Financings
BEATBio is a Seattle, Wash.-based biotechnology company focused on the development of a novel gene therapy for heart failure. BEATBio's technologies were developed by a founding …See details»
BEAT Bio Therapeutics - CoMotion
Jan 1, 2012 BEAT BioTherapeutics is developing BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. BEATBio holds worldwide rights to this …See details»
BEAT BioTherapeutics - Company Information, Competitors, News …
Find useful insights on BEAT BioTherapeutics's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at BEAT …See details»
BEAT BioTherapeutics CEO, Founder, Key Executive Team, Board of ...
Explore {BEAT BioTherapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
BEAT BioTherapeutics - Contacts, Employees, Board Members
BEAT BioTherapeutics has 4 current employee profiles, including Scientific Co-Founder Michael Laflamme. BEAT BioTherapeutics has 1 board member or advisor, Craig Tall . ContactsSee details»
BEAT BioTherapeutics Corporation Closes $2.5MM Seed Financing …
April 16, 2013 BEAT BioTherapeutics Corporation Closes $2.5MM Seed Financing to Develop Its Gene Therapy Treatment for Heart Failure University of Washington spin-out aims to refuel …See details»
BEAT Therapeutics - LinkedIn
BEAT Therapeutics Biotechnology Research Porto, Porto 1,922 followers First-in-class therapy against aggressive cancersSee details»